May 9, 2022 -- Lunaphore installed its Comet Primary Antibodies (PA) instrument at Propath U.K., the first contract research organization (CRO) in Europe to offer the service.
Comet PA is an automated sequential immunofluorescence (seqIF) instrument that performs hyperplex staining and imaging. It allows multiplex analysis of up to 40 different spatial markers per tissue slide without human intervention, according to Lunaphore.
The instrument can aid understanding in the areas of immuno-oncology, neuroscience, and infectious diseases, the firm added.
Copyright © 2022 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
